TY - JOUR
T1 - ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery”
AU - Özer, M. jde
AU - Toulabi, Sahaand Poor
AU - Fisher, Alessandra D.
AU - t'Sjoen, Guy
AU - Buncamper, Marlon E.
AU - Monstrey, Stan
AU - Bizic, Marta R.
AU - Djordjevic, Miroslav
AU - Falcone, Marco
AU - Christopher, Nim A.
AU - Simon, Daniel
AU - Capitán, Luis
AU - Motmans, Joz
N1 - Funding Information:
The authors thank Hans Ket and Ralph de Vries from the VU University Amsterdam, for developing our research strategy. The authors thank dr. Giovanni Corona (Maggiore Hospital, Bologna), dr. Carlo Bettocchi (University of Bari), dr. Yacov Reisman (Amstelland Hospital, Amstelveen), and dr. Gennaro Selvaggi (University of Gothenburg) for their help in revising this position statement.
Publisher Copyright:
© 2021 International Society for Sexual Medicine
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Introduction: Much has been published on the surgical and functional results following Gender Affirming Surgery (‘GAS’) in trans individuals. Comprehensive results regarding sexual wellbeing following GAS, however, are generally lacking. Aim: To review the impact of various GAS on sexual wellbeing in treatment seeking trans individuals, and provide a comprehensive list of clinical recommendations regarding the various surgical options of GAS on behalf of the European Society for Sexual Medicine. Methods: The Medline, Cochrane Library and Embase databases were reviewed on the results of sexual wellbeing after GAS. Main Outcomes Measure: The task force established consensus statements regarding the somatic and general requirements before GAS and of GAS: orchiectomy-only, vaginoplasty, breast augmentation, vocal feminization surgery, facial feminization surgery, mastectomy, removal of the female sexual organs, metaidoioplasty, and phalloplasty. Outcomes pertaining to sexual wellbeing- sexual satisfaction, sexual relationship, sexual response, sexual activity, enacted sexual script, sexuality, sexual function, genital function, quality of sex life and sexual pleasure- are provided for each statement separately. Results: The present position paper provides clinicians with statements and recommendations for clinical practice, regarding GAS and their effects on sexual wellbeing in trans individuals. These data, are limited and may not be sufficient to make evidence-based recommendations for every surgical option. Findings regarding sexual wellbeing following GAS were mainly positive. There was no data on sexual wellbeing following orchiectomy-only, vocal feminization surgery, facial feminization surgery or the removal of the female sexual organs. The choice for GAS is dependent on patient preference, anatomy and health status, and the surgeon's skills. Trans individuals may benefit from studies focusing exclusively on the effects of GAS on sexual wellbeing. Conclusion: The available evidence suggests positive results regarding sexual wellbeing following GAS. We advise more studies that underline the evidence regarding sexual wellbeing following GAS. This position statement may aid both clinicians and patients in decision-making process regarding the choice for GAS. Müjde Özer, Sahaand Poor Toulabi, Alessandra D. Fisher, et al. ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery”. Sex Med 2021;XX:XXXXXX.
AB - Introduction: Much has been published on the surgical and functional results following Gender Affirming Surgery (‘GAS’) in trans individuals. Comprehensive results regarding sexual wellbeing following GAS, however, are generally lacking. Aim: To review the impact of various GAS on sexual wellbeing in treatment seeking trans individuals, and provide a comprehensive list of clinical recommendations regarding the various surgical options of GAS on behalf of the European Society for Sexual Medicine. Methods: The Medline, Cochrane Library and Embase databases were reviewed on the results of sexual wellbeing after GAS. Main Outcomes Measure: The task force established consensus statements regarding the somatic and general requirements before GAS and of GAS: orchiectomy-only, vaginoplasty, breast augmentation, vocal feminization surgery, facial feminization surgery, mastectomy, removal of the female sexual organs, metaidoioplasty, and phalloplasty. Outcomes pertaining to sexual wellbeing- sexual satisfaction, sexual relationship, sexual response, sexual activity, enacted sexual script, sexuality, sexual function, genital function, quality of sex life and sexual pleasure- are provided for each statement separately. Results: The present position paper provides clinicians with statements and recommendations for clinical practice, regarding GAS and their effects on sexual wellbeing in trans individuals. These data, are limited and may not be sufficient to make evidence-based recommendations for every surgical option. Findings regarding sexual wellbeing following GAS were mainly positive. There was no data on sexual wellbeing following orchiectomy-only, vocal feminization surgery, facial feminization surgery or the removal of the female sexual organs. The choice for GAS is dependent on patient preference, anatomy and health status, and the surgeon's skills. Trans individuals may benefit from studies focusing exclusively on the effects of GAS on sexual wellbeing. Conclusion: The available evidence suggests positive results regarding sexual wellbeing following GAS. We advise more studies that underline the evidence regarding sexual wellbeing following GAS. This position statement may aid both clinicians and patients in decision-making process regarding the choice for GAS. Müjde Özer, Sahaand Poor Toulabi, Alessandra D. Fisher, et al. ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery”. Sex Med 2021;XX:XXXXXX.
KW - Gender Affirming Surgery
KW - Gender Diverse
KW - Gender Incongruence
KW - Metaidoioplasty
KW - Phalloplasty
KW - Sexual Wellbeing
KW - Transgender
KW - Transsexual
KW - Vaginoplasty
UR - http://www.scopus.com/inward/record.url?scp=85121990372&partnerID=8YFLogxK
U2 - 10.1016/j.esxm.2021.100471
DO - 10.1016/j.esxm.2021.100471
M3 - Review article
C2 - 34971864
SN - 2050-1161
VL - 10
JO - Sexual medicine
JF - Sexual medicine
IS - 1
M1 - 100471
ER -